ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,106,099 | -72.3% | 1,979,060 | -47.0% | 0.00% | -50.0% |
| Q2 2023 | $79,836,939 | -47.7% | 3,730,698 | -1.2% | 0.00% | -60.0% |
| Q1 2023 | $152,717,698 | -12.6% | 3,776,402 | +0.6% | 0.01% | 0.0% |
| Q4 2022 | $174,641,848 | -7.0% | 3,754,124 | +3.7% | 0.01% | -16.7% |
| Q3 2022 | $187,864,000 | +12.9% | 3,621,795 | +2.9% | 0.01% | +20.0% |
| Q2 2022 | $166,331,000 | -33.6% | 3,518,736 | +0.1% | 0.01% | -28.6% |
| Q1 2022 | $250,312,000 | -3.6% | 3,516,606 | +1.3% | 0.01% | 0.0% |
| Q4 2021 | $259,592,000 | +27.1% | 3,471,415 | -3.4% | 0.01% | +16.7% |
| Q3 2021 | $204,237,000 | +26.4% | 3,595,053 | -2.1% | 0.01% | +50.0% |
| Q2 2021 | $161,606,000 | -12.1% | 3,672,006 | -1.5% | 0.00% | -20.0% |
| Q1 2021 | $183,943,000 | +28.3% | 3,729,571 | +9.5% | 0.01% | 0.0% |
| Q4 2020 | $143,393,000 | -2.6% | 3,406,000 | +5.9% | 0.01% | 0.0% |
| Q3 2020 | $147,206,000 | -3.2% | 3,215,507 | +6.1% | 0.01% | -16.7% |
| Q2 2020 | $152,150,000 | +4.5% | 3,030,291 | +7.0% | 0.01% | -14.3% |
| Q1 2020 | $145,646,000 | -16.5% | 2,831,898 | +0.3% | 0.01% | 0.0% |
| Q4 2019 | $174,441,000 | +11.2% | 2,823,568 | +8.1% | 0.01% | 0.0% |
| Q3 2019 | $156,941,000 | -28.3% | 2,612,191 | +0.8% | 0.01% | -22.2% |
| Q2 2019 | $218,743,000 | -10.4% | 2,592,357 | +1.5% | 0.01% | -18.2% |
| Q1 2019 | $244,047,000 | +33.9% | 2,554,940 | -0.7% | 0.01% | +22.2% |
| Q4 2018 | $182,278,000 | -17.7% | 2,573,488 | -0.6% | 0.01% | -10.0% |
| Q3 2018 | $221,354,000 | -21.5% | 2,590,166 | +6.5% | 0.01% | -23.1% |
| Q2 2018 | $281,985,000 | +47.4% | 2,433,000 | +2.9% | 0.01% | +44.4% |
| Q1 2018 | $191,308,000 | +39.1% | 2,364,436 | +0.9% | 0.01% | +28.6% |
| Q4 2017 | $137,521,000 | +30.8% | 2,343,593 | +4.3% | 0.01% | +40.0% |
| Q3 2017 | $105,138,000 | +32.9% | 2,246,539 | +2.2% | 0.01% | +25.0% |
| Q2 2017 | $79,092,000 | +11.9% | 2,198,197 | -4.2% | 0.00% | 0.0% |
| Q1 2017 | $70,682,000 | +24527.9% | 2,294,887 | +26696.9% | 0.00% | – |
| Q4 2016 | $287,000 | +30.5% | 8,564 | +3.5% | 0.00% | – |
| Q3 2016 | $220,000 | +115.7% | 8,271 | +79.3% | 0.00% | – |
| Q2 2016 | $102,000 | +200.0% | 4,614 | +295.7% | 0.00% | – |
| Q1 2016 | $34,000 | +183.3% | 1,166 | +226.6% | 0.00% | – |
| Q4 2015 | $12,000 | -7.7% | 357 | 0.0% | 0.00% | – |
| Q3 2015 | $13,000 | -18.8% | 357 | 0.0% | 0.00% | – |
| Q2 2015 | $16,000 | +128.6% | 357 | +52.6% | 0.00% | – |
| Q1 2015 | $7,000 | -41.7% | 234 | 0.0% | 0.00% | – |
| Q4 2014 | $12,000 | +33.3% | 234 | 0.0% | 0.00% | – |
| Q3 2014 | $9,000 | -10.0% | 234 | 0.0% | 0.00% | – |
| Q2 2014 | $10,000 | – | 234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |